Establishment and Characterization of a Novel Dedifferentiated Chondrosarcoma Cell Line DDCS2
Background The dedifferentiated variant of chondrosarcoma is highly aggressive and carries an especially grim prognosis. While chemotherapeutics has failed to benefit patients with dedifferentiated chondrosarcoma significantly, preclinical chemosensitivity studies have been limited by a scarcity of...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-11-01
|
Series: | Cancer Control |
Online Access: | https://doi.org/10.1177/10732748211045274 |